Growth Metrics

Jaguar Health (JAGX) Receivables - Other (2016 - 2025)

Jaguar Health (JAGX) has disclosed Receivables - Other for 11 consecutive years, with $177000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 47.5% to $177000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $177000.0 through Dec 2025, up 47.5% year-over-year, with the annual reading at $177000.0 for FY2025, 47.5% up from the prior year.
  • Receivables - Other for Q4 2025 was $177000.0 at Jaguar Health, up from $67000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $634000.0 in Q3 2022, with the low at $30000.0 in Q1 2021.
  • Average Receivables - Other over 5 years is $240500.0, with a median of $168500.0 recorded in 2023.
  • The sharpest move saw Receivables - Other surged 3033.33% in 2021, then tumbled 73.03% in 2023.
  • Over 5 years, Receivables - Other stood at $435000.0 in 2021, then soared by 35.17% to $588000.0 in 2022, then tumbled by 63.1% to $217000.0 in 2023, then plummeted by 44.7% to $120000.0 in 2024, then soared by 47.5% to $177000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $177000.0, $67000.0, and $143000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.